L-(-)-Threonine CAS 72-19-5 - Factory, Suppliers, Manufacturers from China

L-(-)-Threonine CAS 72-19-5, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

L-(-)-Threonine CAS 72-19-5 (H-Thr-OH) Assay 99.0~101.0 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — L-(-)-Threonine CAS 72-19-5 (H-Thr-OH) Assay 99.0~101.0% Factory High Quality
Read More

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...

2022.12.26 07:23:22
2022.11.17 11:43:04
2022.07.03 00:12:32
2022.05.02 03:29:56
2022.01.07 07:37:18
2021.11.03 18:19:21

L-(-)-Threonine CAS 72-19-5 - Factory, Suppliers, Manufacturers from China

Related Products

L-(-)-Threonine CAS 72-19-5 (H-Thr-OH) Assay 99.0~101.0% Factory High Quality

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

2-Fluorothiophenol CAS 2557-78-0 Purity >98.0% (GC) Factory

Boc-D-Phe(3,4-F2)-OH CAS 205445-51-8 Purity >98.5% (HPLC) Factory

Fmoc-Trp-OH CAS 35737-15-6 Fmoc-L-Tryptophan Purity >99.0% (HPLC) Factory

Tos-Phe-OH CAS 13505-32-3 Purity ≥98.0% (HPLC)

H-D-Phe-OtBu·HCl CAS 3403-25-6 Purity >98.0% (HPLC) Factory

Nα-Acetyl-L-Ornithine CAS 6205-08-9 (Ac-Orn-OH) Assay >98.0%

HEPBS CAS 161308-36-7 Purity >99.0% (Titration) Biological Buffer Ultra Pure Grade Factory

Fmoc-Lys-OH·HCl CAS 139262-23-0 Nα-Fmoc-L-Lysine Hydrochloride Purity >98.5% (HPLC)

CAS 848821-58-9 (S)-(-)-α,α-Diphenyl-2-Pyrrolidinemethanol Trimethylsilyl Ether Purity ≥97.0% (GC) Optical Purity ≥98.0%

Pentadecanedioic Acid CAS 1460-18-0 Mono Acid >95.0% Total Acids >98.0%

2,5-Dibromopyridine CAS 624-28-2 Assay ≥99.5% (GC) Factory

n-Pentylboronic Acid CAS 4737-50-2 Purity >98.0% Factory High Quality

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Paxlovid: what we know about Pfizer's Covid-19 pill

New COVID treatments offer hope

2022.12.26 07:23:22

2022.11.17 11:43:04

2022.07.03 00:12:32

2022.05.02 03:29:56

2022.01.07 07:37:18

2021.11.03 18:19:21

related search